advertisement
Abstract #109842 Published in IGR 24-1/2
XEN Gel Stent for Conjunctiva with Minimal Mobility Caused by Scleral Encircling: A Case Report
Kim Y; Kim M; Kim DW; Rho SJournal of clinical medicine 2023; 12:
This case report describes the successful use of a XEN gel stent for controlling intraocular pressure (IOP) in a patient who had previously undergone scleral encircling for rhegmatogenous retinal detachment. The patient had very limited mobile conjunctiva due to scarring caused by the earlier surgery, which limited their options for glaucoma surgery. The XEN gel stent, a minimally invasive glaucoma surgery (MIGS) procedure that does not require opening the conjunctiva, was implanted in the subconjunctival space using an ab interno approach. Postoperative blebs were imaged using anterior segment optical coherence tomography, and IOP was monitored over six months. This study found that the XEN gel stent effectively controlled the IOP, and there were no complications during or after surgery. This case report may expand the indication for the XEN gel stent, which could be considered a viable option for patients who have undergone scleral buckling and have limited mobile conjunctiva.
Department of Ophthalmology, Bundang CHA Medical Center, CHA University, Seongnam 13496, Republic of Korea.
Full article